According to the latest statistics of AR in China, there are more than 200 domestic enterprises engaged in AR application development, of which 80% tend to develop game applications, and the rest tend to live applications such as movies and shopping. However, according to the public information, the current application focused on medical and health fields does not exceed 10.
Overseas, according to the comprehensive data query of CBInsights, CrunchBase and AngelList websites, there are currently about 30 startup companies focusing on AR medical applications. Among them, 9 start-ups received financing, with a total financing amount of 552 million US dollars and an investment rate of 30%.
There are three main categories of clients of the award-winning project: medical institutions, laboratories and blind people. Among them, the main medical institutions are patient virtual information, vascular lighting, surgery teaching, surgery navigation and surgery simulation training. In other words, projects that open the market through service B are more concerned by capital. Therefore, on a global scale, the application of AR in the medical and health field is still in the blue ocean exploration period.
In the industrial chain of AR medical applications, at present, the companies are mainly distributed in four categories: terminal equipment, software, content and application, providing hardware and PC application software for end users, and most of them rely on direct selling products for profit.
At present, the market is far from mature. However, it also attracted some leading industrial giants to participate.
The most famous is Microsoft HoloLens holographic glasses. In the official promotional video, medical researchers can view the structure of human organs, muscle tissues and human bones through HoloLens, which is also the most powerful AR device at present. Also, for example, the 3D augmented reality system designed by the game giant Fantasy is used to help doctors better perform cosmetic surgery; And the AR application jointly developed by Philips Healthcare and Accenture allows doctors to monitor patients' vital signs at any time and receive alerts when potential risk problems are detected.